Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Shares Outstanding (Diluted Average) (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $341541.0 as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 27.07% to $341541.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $341541.0 through Dec 2025, up 27.07% year-over-year, with the annual reading at $341541.0 for FY2025, 27.07% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $341541.0 at Nuvation Bio, roughly flat from $340597.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $341541.0 in Q4 2025, with the low at $218741.0 in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $267945.2, with a median of $245311.5 recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) increased 0.14% in 2024, then skyrocketed 54.58% in 2025.
  • Over 3 years, Shares Outstanding (Diluted Average) stood at $218880.0 in 2023, then rose by 22.79% to $268772.0 in 2024, then grew by 27.07% to $341541.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $341541.0, $340597.0, and $340746.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.